Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claes Andersson

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Bone Reports|June 21, 2021
Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytesKonstantin Byrgazov, Thomas Lind, Annica J Rasmusson, et al.
Scientific Reports|May 27, 2022
Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinomaFrida Ek, Kristin Blom, Tove Selvin, et al.
International Journal of Oncology|September 9, 2022
<i>Ex vivo</i> assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcomeKathrine Bjersand, Kristin Blom, Inger Sundström Poromaa, et al.
BMC Research Notes|April 24, 2019
Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibitionKristin Blom, Jenny Rubin, Malin Berglund, et al.
JMIR Formative Research|January 15, 2026
Personalized Transdiagnostic Cognitive Behavior Therapy With Midtreatment Stepped Care to Improve Mental Health Among University Students in Sweden: Feasibility Study for a Randomized Controlled TrialNaira Topooco, Philip Lindner, Claes Andersson, et al.
Communications Medicine|April 11, 2026
An integrative molecular map of pediatric B-cell precursor acute lymphoblastic leukemiaOlga Krali, Anna Pia Enblad, Julia Sulyaeva, et al.
Immunopharmacology and Immunotoxicology|May 6, 2017
The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activationKristin Blom, Wojciech Senkowski, Malin Jarvius, et al.
Experimental Cell Research|November 7, 2017
Targeting tumor cells based on Phosphodiesterase 3A expressionMadiha Nazir, Wojciech Senkowski, Frida Nyberg, et al.
Human Molecular Genetics|August 21, 2008
Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis miceJudith Blanz, Stijn Stroobants, Renate Lüllmann-Rauch, et al.
Human Molecular Genetics|July 23, 2004
Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal studyDiego Prieto Roces, Renate Lüllmann-Rauch, Jianhe Peng, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Bone Reports|June 21, 2021
Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytesKonstantin Byrgazov, Thomas Lind, Annica J Rasmusson, et al.
Scientific Reports|May 27, 2022
Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinomaFrida Ek, Kristin Blom, Tove Selvin, et al.
International Journal of Oncology|September 9, 2022
<i>Ex vivo</i> assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcomeKathrine Bjersand, Kristin Blom, Inger Sundström Poromaa, et al.
BMC Research Notes|April 24, 2019
Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibitionKristin Blom, Jenny Rubin, Malin Berglund, et al.
JMIR Formative Research|January 15, 2026
Personalized Transdiagnostic Cognitive Behavior Therapy With Midtreatment Stepped Care to Improve Mental Health Among University Students in Sweden: Feasibility Study for a Randomized Controlled TrialNaira Topooco, Philip Lindner, Claes Andersson, et al.
Communications Medicine|April 11, 2026
An integrative molecular map of pediatric B-cell precursor acute lymphoblastic leukemiaOlga Krali, Anna Pia Enblad, Julia Sulyaeva, et al.
Immunopharmacology and Immunotoxicology|May 6, 2017
The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activationKristin Blom, Wojciech Senkowski, Malin Jarvius, et al.
Experimental Cell Research|November 7, 2017
Targeting tumor cells based on Phosphodiesterase 3A expressionMadiha Nazir, Wojciech Senkowski, Frida Nyberg, et al.
Human Molecular Genetics|August 21, 2008
Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis miceJudith Blanz, Stijn Stroobants, Renate Lüllmann-Rauch, et al.
Human Molecular Genetics|July 23, 2004
Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal studyDiego Prieto Roces, Renate Lüllmann-Rauch, Jianhe Peng, et al.
Pageof 10